胶囊内镜在家族性类癌患者中检测小肠神经内分泌肿瘤的性能:一项前瞻性单中心研究
研究纳入174例有家族性小肠神经内分泌肿瘤家族史的无症状受试者,均行小肠胶囊内镜和18F-DOPA PET/CT检查,阳性者手术探查。35例影像阳性,32例手术确诊;胶囊内镜患者水平灵敏度87.5%、特异度97.3%、阴性预测值96.5%,与18F-DOPA PET/CT灵敏度84%相当。
要点
- 小肠胶囊内镜筛查家族性小肠神经内分泌肿瘤高危无症状亲属,患者水平灵敏度87.5%、特异度97.3%。
- 18F-DOPA PET/CT灵敏度84%,与小肠胶囊内镜相近。
- 确诊患者平均肿瘤数目7.7个、大小5.0 mm,81.2%为多发性肿瘤。
核心结论
- 小肠胶囊内镜是筛查家族性小肠神经内分泌肿瘤高危患者敏感且特异的方法,与18F-DOPA PET/CT相当。
研究设计与样本
- 前瞻性单中心研究,纳入174例有家族性小肠神经内分泌肿瘤家族史(≥2名家庭成员)的无症状受试者,方案编号NCT00646022。
- 所有患者均行小肠胶囊内镜和18F-DOPA PET/CT检查,结果独立分析,影像阳性者行手术探查。
主要发现
- 174例无症状受试者中35例小肠胶囊内镜或18F-DOPA PET阳性,35例中32例经手术确诊。
- 小肠胶囊内镜在32例确诊肿瘤患者中28例阳性,患者水平灵敏度87.5%、特异度97.3%、阴性预测值96.5%。
- 确诊患者平均肿瘤数目7.7个、平均大小5.0 mm,81.2%的患者为多发性肿瘤。
- 18F-DOPA PET/CT与手术相比灵敏度84%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Small-bowel neuroendocrine tumors (NETs) are slow growing, clinically silent tumors whose prognosis depends on disease stage. Members of kindreds with a familial form of small intestinal NETs (SI-NETs) represent a high-risk population for whom early detection improves disease outcome. Our aim was to determine the utility of small-bowel capsule endoscopy (SB-CE) for screening high-risk asymptomatic relatives from kindreds with familial carcinoid. METHODS: One hundred seventy-four asymptomatic subjects with a family history (≥2 family members) of SI-NETs were screened under Protocol NCT00646022, Natural History of Familial Carcinoid Tumor at the National Institutes of Health. All patients were imaged with SB-CE and 18fluoro-dihydroxphenylalanine (18F-DOPA) positron emission tomography (PET)/CT, and results were independently analyzed. Patients with a positive imaging study underwent surgical exploration. RESULTS: Thirty-five of 174 asymptomatic subjects screened for SI-NETs were positive on either SB-CE or 18F-DOPA PET. Thirty-two of 35 patients with a positive study were confirmed at surgery. SB-CE was positive in 28 of 32 patients with confirmed tumors for a per-patient sensitivity of 87.5%. SB-CE had a specificity of 97.3% and a negative predictive value of 96.5%. The average tumor number and size were 7.7 and 5.0 mm, respectively, and 81.2% of patients had multiple tumors. 18F-DOPA PET/CT had a similar sensitivity of 84% versus surgery. CONCLUSIONS: SB-CE is a sensitive and specific method comparable with 18F-DOPA PET/CT for screening high-risk patients with familial SI-NET. (Clinical trial registration number: NCT00646022.).
引用
- Tang D, Lim R, Korman L, et al. Performance of capsule endoscopy for the detection of small intestinal neuroendocrine tumors in familial carcinoid: a prospective single-site study. Gastrointest Endosc. 2023. PMID: 37838323. doi:10.1016/j.gie.2023.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。